ostarine cycle length in the enobosarm trials ran 86 to 147 days once daily, while published liver injury cases followed about six weeks of exposure.
MoreOstarine course length: trial durations and what is reported
RAD 140 suppression and recovery: what the evidence shows
No published study has tested PCT for RAD 140, and a case report records suppressed testosterone normalising once supplements containing it were stopped.
MoreRAD 140 half life: the trial figure, timing and onset
The RAD 140 half life measured in its one human trial was about 44.7 hours, the figure behind once-daily administration in women with breast cancer.
MoreRAD140 dose: what the trials gave and the evidence covers
No RAD140 dose is approved: its dose-finding trial gave 50, 100 or 150 mg daily in breast cancer, and a later vosilasarm study gave 10 mg twice daily.
More






